Here’s our fortnightly wrap of all the news driving ASX health stocks.

Of the ASX’s 137-odd small cap health stocks, 68 saw their share prices fall, 55 improved and 14 were flat.

Code Name Price (Feb 19) 2 week return % 1 year return % Market cap
HCT HOLISTA COLLTECH LTD 0.210 147 279 $57,909,660
ZNO ZOONO GROUP LTD 1.790 109 1848 $308,661,024
UCM USCOM LTD 0.335 94 169 $52,320,752
RAC RACE ONCOLOGY LTD 0.400 67 388 $44,749,408
OVN OVENTUS MEDICAL LTD 0.550 51 103 $73,096,640
MX1 MICRO-X LTD 0.185 50 -15 $48,753,988
RCE RECCE PHARMACEUTICALS LTD 0.518 44 215 $69,817,312
MEM MEMPHASYS LTD 0.063 34 156 $47,500,356
BIT BIOTRON LTD 0.120 34 28 $80,722,264
ATX AMPLIA THERAPEUTICS LTD 0.089 32 -35 $6,247,540
PIQ PROTEOMICS INTERNATIONAL LAB 0.350 31 0 $31,239,498
ANP ANTISENSE THERAPEUTICS LTD 0.087 28 129 $38,125,252
CMP COMPUMEDICS LTD 0.863 28 157 $155,017,584
NOX NOXOPHARM LTD 0.265 27 -30 $37,016,052
S66 STAR COMBO PHARMA LTD 0.565 23 -7 $48,893,180
AZV AZURE HEALTHCARE LTD 0.115 22 97 $31,260,784
IMM IMMUTEP LTD 0.445 22 27 $152,736,064
SDI SDI LTD 1.015 16 26 $118,865,528
BD1 BARD1 LIFE SCIENCES LTD 0.038 16 96 $50,585,844
TLX TELIX PHARMACEUTICALS LTD 1.640 15 135 $416,916,736
AHX APIAM ANIMAL HEALTH LTD 0.530 15 19 $62,577,576
AVH AVITA MEDICAL LTD 0.838 15 482 $1,725,741,568
CAJ CAPITOL HEALTH LTD 0.278 12 17 $215,151,840
BWX BWX LTD 4.465 12 186 $562,851,968
ALC ALCIDION GROUP LTD 0.205 10 450 $217,952,688
SVA SIMAVITA LTD-CDI 0.023 10 35 $9,608,897
IMU IMUGENE LTD 0.034 9 106 $154,908,976
PBP PROBIOTEC LTD 2.400 9 63 $180,964,864
CGS COGSTATE LTD 0.490 9 10 $82,575,616
ICS ICSGLOBAL LTD 1.995 9 131 $21,155,018
DVL DORSAVI LTD 0.021 8 -39 $6,248,543
ADO ANTEOTECH LTD 0.030 7 69 $43,509,128
PNV POLYNOVO LTD 3.220 7 345 $2,042,762,112
PYC PYC THERAPEUTICS LTD 0.064 7 156 $187,611,392
HLA HEALTHIA LTD 1.305 7 27 $82,260,224
PSQ PACIFIC SMILES GROUP LTD 1.860 6 41 $284,987,616
PAB PATRYS LTD 0.017 6 -18 $19,306,626
VBS VECTUS BIOSYSTEMS LTD 0.580 5 66 $13,719,793
EHH EAGLE HEALTH HOLDINGS LTD 0.120 4 -53 $42,133,992
SKN SKIN ELEMENTS LTD 0.014 4 -18 $2,934,004
PAL PALLA PHARMA LTD 0.845 4 -14 $106,426,040
DXB DIMERIX LTD 0.145 4 71 $26,321,374
IBX IMAGION BIOSYSTEMS LTD 0.030 3 3 $15,338,466
M7T MACH7 TECHNOLOGIES LTD 0.840 3 328 $156,318,912
ACR ACRUX LTD 0.175 3 0 $29,289,674
LSH LIFESPOT HEALTH LTD 0.035 3 -50 $2,714,904
BLT BENITEC BIOPHARMA LTD 0.036 3 -70 $11,566,333
JHC JAPARA HEALTHCARE LTD 0.950 3 -27 $259,229,904
MVF MONASH IVF GROUP LTD 0.995 3 14 $238,143,744
SUD SUDA PHARMACEUTICALS LTD 0.055 2 -54 $7,823,992
ELX ELLEX MEDICAL LASERS LTD 0.830 2 38 $119,188,944
IMC IMMURON LTD 0.135 2 -47 $24,810,576
SOM SOMNOMED LTD 3.270 1 104 $208,509,840
RSH RESPIRI LTD 0.081 1 2 $47,281,940
ONT 1300 SMILES LTD 6.350 1 7 $150,357,744
NVL NATIONAL VETERINARY CARE LTD 3.680 0 92 $246,811,920
RAP RESAPP HEALTH LTD 0.240 0 161 $167,101,328
PAA PHARMAUST LTD 0.105 0 213 $31,712,210
FTT FACTOR THERAPEUTICS LTD 0.003 0 -17 $2,607,089
MDR MEDADVISOR LTD 0.500 0 93 $122,970,536
ALT ANALYTICA LTD 0.003 0 -40 $10,558,837
LCT LIVING CELL TECHNOLOGIES LTD 0.019 0 -51 $10,857,379
BPH BPH ENERGY LTD 0.001 0 0 $3,341,463
VTI VISIONEERING TECH-CDI 0.039 0 -63 $18,166,270
GTG GENETIC TECHNOLOGIES LTD 0.010 0 34 $40,631,340
FFC FARMAFORCE LTD 0.090 0 0 $11,589,388
NYR NYRADA INC-CDI 0.205 0 $22,423,664
OCC ORTHOCELL LTD 0.475 0 288 $89,412,064
MVP MEDICAL DEVELOPMENTS INTERNA 10.390 0 184 $711,182,784
THC THC GLOBAL GROUP LTD 0.370 -1 -32 $52,084,732
AC8 AUSCANN GROUP HOLDINGS LTD 0.305 -2 -34 $95,114,208
1ST 1ST GROUP LTD 0.057 -2 97 $24,203,164
CYC CYCLOPHARM LTD 1.100 -2 1 $86,062,240
NEU NEUREN PHARMACEUTICALS LTD 2.600 -2 113 $283,717,568
OPT OPTHEA LTD 3.480 -2 361 $893,603,776
BOT BOTANIX PHARMACEUTICALS LTD 0.089 -3 -9 $88,515,520
LBT LBT INNOVATIONS LTD 0.140 -3 105 $35,330,968
ANR ANATARA LIFESCIENCES LTD 0.240 -4 -41 $12,962,606
PXS PHARMAXIS LTD 0.115 -4 -56 $45,393,972
GSS GENETIC SIGNATURES LTD 1.140 -4 22 $163,673,456
OSX OSTEOPORE LTD 0.600 -5 $59,725,996
CDY CELLMID LTD 0.185 -5 -12 $17,870,420
UBI UNIVERSAL BIOSENSORS INC-CDI 0.175 -5 -27 $31,053,932
OSL ONCOSIL MEDICAL LTD 0.165 -6 3 $107,220,496
CTE CRYOSITE LTD 0.050 -6 22 $2,342,978
PTX PRESCIENT THERAPEUTICS LTD 0.053 -6 -28 $19,713,032
NSB NEUROSCIENTIFIC BIOPHARMACEU 0.165 -6 -18 $12,933,456
OIL OPTISCAN IMAGING LTD 0.033 -6 -42 $15,766,700
CYP CYNATA THERAPEUTICS LTD 1.050 -6 -33 $107,653,968
CAN CANN GROUP LTD 1.090 -6 -37 $158,088,496
IHL IMPRESSION HEALTHCARE LTD 0.061 -6 244 $44,479,788
MDC MEDLAB CLINICAL LTD 0.305 -6 -22 $71,132,656
VLS VITA LIFE SCIENCES LTD 0.590 -6 -16 $32,203,742
GLH GLOBAL HEALTH LTD 0.140 -7 -7 $5,893,765
VHT VOLPARA HEALTH TECHNOLOGIES 1.680 -7 66 $364,594,368
TD1 TALI DIGITAL LTD 0.041 -7 60 $29,972,208
CDX CARDIEX LTD 0.026 -7 -62 $18,830,232
BNO BIONOMICS LTD 0.062 -8 -63 $33,225,838
RHY RHYTHM BIOSCIENCES LTD 0.092 -8 -32 $9,269,000
KZA KAZIA THERAPEUTICS LTD 0.575 -8 25 $41,495,836
MMJ MMJ GROUP HOLDINGS LTD 0.110 -8 -56 $24,683,888
RNO RHINOMED LTD 0.160 -9 0 $27,072,962
ACW ACTINOGEN MEDICAL LTD 0.031 -9 -43 $34,603,172
IVX INVION LTD 0.010 -9 -41 $55,006,064
ESE ESENSE-LAB LTD-CDI 0.010 -9 -57 $1,900,769
PAR PARADIGM BIOPHARMACEUTICALS 3.870 -9 252 $781,365,696
IDT IDT AUSTRALIA LTD 0.135 -10 -18 $31,988,676
ONE ONEVIEW HEALTHCARE PLC-CDI 0.135 -10 -72 $23,383,550
ZLD ZELIRA THERAPEUTICS LTD 0.062 -11 5 $50,717,708
MEB MEDIBIO LTD 0.008 -11 -64 $7,961,041
ADR ADHERIUM LTD 0.031 -11 45 $15,905,413
RHT RESONANCE HEALTH LTD 0.195 -11 186 $86,176,784
RGS REGENEUS LTD 0.063 -11 -50 $17,502,974
SDX SIENNA CANCER DIAGNOSTICS LT 0.038 -12 -41 $15,015,048
PGC PARAGON CARE LTD 0.275 -12 -37 $96,297,312
IPD IMPEDIMED LTD 0.105 -13 -56 $53,660,176
AVE AVECHO BIOTECHNOLOGY LTD 0.004 -13 -13 $5,521,101
NTI NEUROTECH INTERNATIONAL LTD 0.007 -13 -75 $950,207
APH AUSTRALIAN PRIMARY HEMP LTD 0.135 -13 -25 $9,386,568
AGH ALTHEA GROUP HOLDINGS LTD 0.365 -14 -9 $85,158,152
ATH ALTERITY THERAPEUTICS LTD 0.017 -15 -58 $15,170,289
JHL JAYEX HEALTHCARE LTD 0.022 -15 -15 $3,797,487
MXC MGC PHARMACEUTICALS LTD 0.028 -16 -31 $37,020,316
SIL SMILES INCLUSIVE LTD 0.040 -17 -85 $5,329,827
1AD ADALTA LTD 0.083 -17 -64 $13,607,486
CP1 CANNPAL ANIMAL THERAPEUTICS 0.130 -17 -4 $11,175,000
NXS NEXT SCIENCE LTD 2.000 -18 $363,721,920
NC6 NANOLLOSE LTD 0.059 -19 -26 $4,425,000
GMV G MEDICAL INNOVATION HOLDING 0.085 -20 -71 $36,621,456
PCK PAINCHEK LTD 0.120 -21 156 $119,085,080
SCU STEMCELL UNITED LTD 0.014 -22 -30 $8,982,517
CPH CRESO PHARMA LTD 0.120 -23 -68 $24,937,124
BXN BIOXYNE LTD 0.013 -24 -50 $8,321,890
EXL ELIXINOL GLOBAL LTD 0.565 -26 -85 $76,531,232
AMT ALLEGRA ORTHOPAEDICS LTD 0.110 -30 -30 $13,938,267
TDL TBG DIAGNOSTICS LTD 0.022 -31 -48 $4,786,921
OSP OSPREY MEDICAL INC-CDI 0.018 -32 -84 $7,340,556

Every opportunistic player has been jumping on the COVID-19 play, which has seen share prices rocket and companies blatantly bandwagon like Food Revolution (ASX:FOD), which says it has cleared a factory floor to cater to a demand for hand sanitiser which — if you believe the Chinese — only has a few more weeks to run.

But had you been reading the tea leaves in December, in the style of Axe from Billions, maybe you’d have collected a coronavirus portfolio something like this, and made a big pile of money.

The top three winners from the last fortnight are of course the leaders of any Chinese disease portfolio — at least in terms of market returns.

The first two sell hand sanitiser and have been successfully convincing investors of shortages in their respective markets, and the third sells blood flow monitoring units, which China is now recommending to be used on critical COVID-19 cases.

Micro-X (ASX:MX1) is up there, after saying China wants more of its mini x-rays to look inside victims’ chests, and Aeris Environmental (ASX:AEI) — not a health company — is also a COVID-19 beneficiary after the Singapore National Environmental Agency (NEA) said its hospital-grade disinfectant was added to a list of approved general products for virus disinfection.

The last is Biotron (ASX:BIT), which is not a company shy of the big issues. It hit the bit time in late 2018 with positive clinical trial data around an HIV cure, but hasn’t had much news to share with investors since.

But at the start of February the company said it had been tinkering with its compounds and coronavirus generally (a family of viruses that at its weakest causes the common cold).

In the lab, Biotron can kill 90-100 per cent of a coronavirus-infected cell.

The company says it’s focused on testing a select few compounds, but it’ll no doubt take more than a promising compound to get into the few labs in the world that have access to the Chinese form of the virus.

Investors would be wise to remember too that all kinds of things have been shown to work in the lab, from vitamin C killing cancer cells to bleach.